332 related articles for article (PubMed ID: 19861957)
1. PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis.
Granito A; Yang WH; Muratori L; Lim MJ; Nakajima A; Ferri S; Pappas G; Quarneti C; Bianchi FB; Bloch DB; Muratori P
Am J Gastroenterol; 2010 Jan; 105(1):125-31. PubMed ID: 19861957
[TBL] [Abstract][Full Text] [Related]
2. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis.
Mytilinaiou MG; Meyer W; Scheper T; Rigopoulou EI; Probst C; Koutsoumpas AL; Abeles D; Burroughs AK; Komorowski L; Vergani D; Bogdanos DP
Clin Chim Acta; 2012 Aug; 413(15-16):1211-6. PubMed ID: 22503841
[TBL] [Abstract][Full Text] [Related]
4. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis.
Muratori P; Muratori L; Ferrari R; Cassani F; Bianchi G; Lenzi M; Rodrigo L; Linares A; Fuentes D; Bianchi FB
Am J Gastroenterol; 2003 Feb; 98(2):431-7. PubMed ID: 12591064
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis.
Granito A; Muratori P; Muratori L; Pappas G; Cassani F; Worthington J; Ferri S; Quarneti C; Cipriano V; de Molo C; Lenzi M; Chapman RW; Bianchi FB
Aliment Pharmacol Ther; 2007 Sep; 26(6):831-8. PubMed ID: 17767467
[TBL] [Abstract][Full Text] [Related]
6. [Patterns of anti-nuclear antibodies in patients with primary biliary cirrhosis and primary Sjögren syndrome].
You X; Liu W; Zhang X; Zhang FC
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):168-70. PubMed ID: 18361813
[TBL] [Abstract][Full Text] [Related]
7. [Anti-Sp100 and anti-Gp210 in the diagnosis of primary biliary cirrhosis in patients with autoimmune cholangitis].
Romero Gómez M; Wichmann I; Otero Fernández MA; Suárez García E; Grande L; Núñez J; Nevado Santos M; Castro Fernández M
Gastroenterol Hepatol; 1999 Jan; 22(1):11-3. PubMed ID: 10089705
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis.
Züchner D; Sternsdorf T; Szostecki C; Heathcote EJ; Cauch-Dudek K; Will H
Hepatology; 1997 Nov; 26(5):1123-30. PubMed ID: 9362351
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two ELISA assays for anti-Sp100 determination.
Manuel Lucena J; Montes Cano M; Luis Caro J; Respaldiza N; Alvarez A; Sánchez-Román J; Núñez-Roldán A; Wichmann I
Ann N Y Acad Sci; 2007 Aug; 1109():203-11. PubMed ID: 17785307
[TBL] [Abstract][Full Text] [Related]
10. Analysis of a multiple nuclear dots pattern in a large cohort of dermatological patients.
Cozzani E; Drosera M; Riva S; Parodi A
Clin Lab; 2012; 58(3-4):329-32. PubMed ID: 22582508
[TBL] [Abstract][Full Text] [Related]
11. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
[TBL] [Abstract][Full Text] [Related]
12. Small ubiquitin-related modifiers: A novel and independent class of autoantigens in primary biliary cirrhosis.
Janka C; Selmi C; Gershwin ME; Will H; Sternsdorf T
Hepatology; 2005 Mar; 41(3):609-16. PubMed ID: 15726652
[TBL] [Abstract][Full Text] [Related]
13. The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome.
Muratori P; Granito A; Pappas G; Pendino GM; Quarneti C; Cicola R; Menichella R; Ferri S; Cassani F; Bianchi FB; Lenzi M; Muratori L
Am J Gastroenterol; 2009 Jun; 104(6):1420-5. PubMed ID: 19491855
[TBL] [Abstract][Full Text] [Related]
14. Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis.
Cavazzana I; Ceribelli A; Taraborelli M; Fredi M; Norman G; Tincani A; Satoh M; Franceschini F
J Rheumatol; 2011 Oct; 38(10):2180-5. PubMed ID: 21921093
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of anti-multiple nuclear dots/Sp100 autoantibodies.
Wichmann I; Montes-Cano MA; Respaldiza N; Alvarez A; Walter K; Franco E; Sanchez-Roman J; Núñez-Roldán A
Scand J Gastroenterol; 2003 Sep; 38(9):996-9. PubMed ID: 14531539
[TBL] [Abstract][Full Text] [Related]
16. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.
Luettig B; Boeker KH; Schoessler W; Will H; Loges S; Schmidt E; Worman HJ; Gershwin ME; Manns MP
J Hepatol; 1998 May; 28(5):824-8. PubMed ID: 9625318
[TBL] [Abstract][Full Text] [Related]
17. Multiple nuclear dot antinuclear antibody in patients without primary biliary cirrhosis.
Kurien BT; Scofield RH
Indian J Biochem Biophys; 1998 Feb; 35(1):41-7. PubMed ID: 9699418
[TBL] [Abstract][Full Text] [Related]
18. Antinuclear antibodies in primary biliary cirrhosis.
Invernizzi P; Selmi C; Ranftler C; Podda M; Wesierska-Gadek J
Semin Liver Dis; 2005 Aug; 25(3):298-310. PubMed ID: 16143945
[TBL] [Abstract][Full Text] [Related]
19. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis.
Liu H; Norman GL; Shums Z; Worman HJ; Krawitt EL; Bizzaro N; Vergani D; Bogdanos DP; Dalekos GN; Milkiewicz P; Czaja AJ; Heathcote EJ; Hirschfield GM; Tan EM; Miyachi K; Bignotto M; Battezzati PM; Lleo A; Leung PS; Podda M; Gershwin ME; Invernizzi P
J Autoimmun; 2010 Dec; 35(4):436-42. PubMed ID: 20932720
[TBL] [Abstract][Full Text] [Related]
20. Clinical correlation of antimitochondrial antibodies.
Zuber MA; Recktenwald C
Eur J Med Res; 2003 Feb; 8(2):61-70. PubMed ID: 12626283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
